Anti-Aging Clinic Hong Kong: What's Available & What to Look For (2026)
Anti-Ageing Medicine in Hong Kong Has Matured — But Quality Still Varies Considerably
Demand for anti-ageing and longevity treatments in Hong Kong has grown substantially over the past five years. The patient profile has changed too: it is less about aesthetic procedures and increasingly about clinical interventions that address the biology of ageing — cellular function, metabolic health, hormonal balance, inflammation, and recovery.
This shift has been driven partly by the broader longevity science movement and the research coming out of institutions like Harvard, Stanford, and the Salk Institute on sirtuins, NAD+, senolytics, and the mechanisms of cellular ageing. Patients are more informed than they used to be, and more interested in treatments that work at a biological rather than cosmetic level.
The challenge is that the market for anti-ageing medicine is broad and inconsistently regulated. The distance between an evidence-based longevity programme and a wellness spa offering "anti-ageing" facials can be significant, even if they both operate under similar marketing language. This guide helps you understand what legitimate anti-ageing clinical interventions look like, what to evaluate when choosing a clinic, and how REVIV's approach is structured.
What Does Evidence-Based Anti-Ageing Medicine Actually Include?
In a clinical context, anti-ageing medicine focuses on interventions that target the biological mechanisms of ageing — not cosmetic treatments that change how you look. The distinction matters because only the former is likely to have meaningful impact on how you function and feel over time.
NAD+ IV therapy
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential to energy production, DNA repair, and cellular stress responses. Its levels decline by approximately 50% between ages 40 and 60, contributing to reduced mitochondrial function, impaired cellular repair, and increased inflammatory burden. IV NAD+ restores circulating levels directly, bypassing the digestive system and achieving bioavailability that oral supplements cannot match. The evidence base — while still developing in human trials — is mechanistically robust and increasingly supported by RCT data.
GLP-1 and metabolic optimisation
Metabolic health is central to healthy ageing. Chronic insulin resistance, visceral adiposity, and metabolic syndrome accelerate biological ageing through multiple pathways — increased inflammation, oxidative stress, mitochondrial impairment, and elevated cardiovascular risk. GLP-1 receptor agonists (Ozempic, Mounjaro) address metabolic dysfunction directly. For patients with excess weight or insulin resistance, GLP-1 therapy is among the most impactful anti-ageing interventions available from a metabolic health perspective.
Peptide therapy
Growth hormone declines progressively from the mid-20s. Peptides that stimulate the body's own GH production (CJC-1295, ipamorelin) can partially restore growth hormone signalling — with downstream effects on fat metabolism, lean muscle mass, sleep quality, and recovery. This has genuine relevance for healthy ageing, particularly in the body composition and physical resilience dimensions. BPC-157 and epithalon are used in longevity protocols for tissue repair and cellular maintenance respectively.
IV nutritional therapy
Nutritional deficiencies are common in the ageing population — often subclinical but functionally significant. Reduced stomach acid production, medication interactions, and reduced dietary diversity all reduce micronutrient absorption over time. IV delivery bypasses these limitations, achieving plasma concentrations that oral supplementation cannot reliably produce for nutrients like glutathione, vitamin C, and B vitamins. Glutathione IV therapy is particularly relevant in the anti-ageing context: glutathione is the body's primary intracellular antioxidant, and levels decline with age and chronic oxidative stress.
Hormonal and metabolic monitoring
A comprehensive anti-ageing programme should include regular monitoring of hormonal and metabolic markers — not just standard annual bloods. Relevant markers include IGF-1 (growth hormone activity), sex hormones, thyroid function, inflammatory markers (hsCRP, IL-6), fasting insulin, HbA1c, and comprehensive lipid fractionation. Tracking these over time allows the programme to be adjusted based on actual biological changes rather than symptoms alone.
What to Look For When Choosing a Clinic
Not all clinics offering anti-ageing or longevity treatments operate at the same standard. Questions worth asking:
Is there a registered doctor involved?
Any clinic prescribing GLP-1 medications, hormonal treatments, or IV therapies should have a Medical Council of Hong Kong registered doctor overseeing the programme. Treatments administered without medical oversight — by nurses or wellness therapists operating independently — are not appropriate for clinical interventions.
Do they take a baseline before treating?
A serious longevity programme starts with blood work. There is no rational basis for an anti-ageing programme that doesn't begin with an understanding of your current biological state. Clinics that move directly to selling treatments without assessment are selling wellness experiences, not medical programmes.
Are the treatments explained with evidence?
You should be able to ask what the evidence base is for any treatment and get a clear, honest answer — including acknowledgement of where the evidence is strong, where it is promising but early, and where it is mostly marketing. Clinics that claim everything works and nothing has caveats are not the ones to trust.
What is the sourcing of injectables?
For IV therapies and peptides, pharmaceutical-grade sourcing from verified suppliers matters. Products of unknown purity, dosed inconsistently, or improperly stored cannot be expected to produce the intended effects and may cause harm.
Is there ongoing monitoring? A one-time treatment is not a longevity programme. Legitimate programmes include follow-up, bloodwork at intervals, and adjustment based on response. If there is no monitoring component, the "programme" is a product sale.
Anti-Ageing Treatments in Hong Kong: What's Available and What to Expect
Hong Kong's private medical market includes a range of anti-ageing offerings, from legitimate clinical programmes to aesthetic-focused wellness centres. The most relevant clinical options:
IV longevity therapy: Available at REVIV and a small number of other medically supervised IV clinics. NAD+, glutathione, high-dose vitamin C, and bespoke nutritional infusions. The key differentiator is medical oversight, verified sourcing, and dose management.
GLP-1 weight management: Available through private GPs, specialist clinics, and structured wellness programmes like REVIV. Both Ozempic (semaglutide) and Mounjaro (tirzepatide) are available on prescription in Hong Kong.
Peptide therapy: Available at a smaller number of clinics with clinical expertise in peptide protocols. Most require a consultation, baseline bloods, and an individualised protocol.
Hormone replacement and optimisation: Available through private GPs, endocrinologists, and some functional medicine clinics. Particularly relevant for women in perimenopause or menopause, and men with androgen decline.
Aesthetic anti-ageing: Botox, fillers, laser treatments, and similar procedures are widely available. These address the cosmetic dimensions of ageing and are outside the scope of clinical longevity medicine — though both dimensions are legitimate goals depending on the patient's priorities.
How REVIV's Anti-Ageing Programme Is Structured
REVIV takes a programme-based approach to anti-ageing and longevity — not a menu of standalone treatments. The process begins with understanding where the patient is biologically and what their goals are, then designing a protocol that makes rational sense for that individual.
A typical starting point for a new anti-ageing patient at REVIV:
Initial consultation with a doctor — health history, current medications, goals, any specific concerns
Comprehensive baseline blood panel — including metabolic, hormonal, and inflammatory markers beyond a standard health check
Protocol design — typically combining NAD+ IV (for cellular energy and repair), IV nutritional support (glutathione, vitamin C, B vitamins), and where appropriate, GLP-1 therapy (for metabolic health) and peptide protocols (for body composition and recovery)
Programme rhythm — IV therapy sessions on a regular schedule (monthly or more frequent initially), follow-up bloods at 3–6 months, adjustments based on results and response
The programme is built around the patient's specific biological profile and goals rather than a fixed package. Patients interested purely in IV longevity therapy, those who want GLP-1 as a metabolic intervention, and those combining multiple modalities all start with the same consultation-first approach.
Frequently Asked Questions
What is the most effective anti-ageing treatment available in Hong Kong?
There is no single answer — it depends on the individual's biological profile and what aspects of ageing are most significant for them. For patients with metabolic issues, GLP-1 therapy may be the highest-impact intervention. For those with energy and cognitive decline, NAD+ IV may be most relevant. For body composition concerns, peptide therapy alongside nutrition and exercise is often most appropriate. Comprehensive programmes address multiple dimensions simultaneously.
How is anti-ageing medicine different from standard medical care?
Standard medical care focuses primarily on diagnosing and treating disease. Anti-ageing or longevity medicine focuses on optimising biological function and delaying the processes that lead to age-related disease and decline — operating in a space between current health and disease prevention. The goal is not just the absence of illness but maintained vitality, cognitive function, physical capability, and resilience.
At what age should I start an anti-ageing programme?
The biological processes that drive ageing begin decades before their effects are apparent. NAD+ decline begins measurably in the 30s. Growth hormone falls from the mid-20s. Metabolic resilience begins to change from 35 onward. That said, the clearest functional benefit from most interventions is seen from 40 onwards, when changes in energy, body composition, recovery, and cognitive performance become more noticeable. There is no single right answer — earlier intervention generally means more preventive, later intervention means more corrective.
Are anti-ageing treatments covered by insurance in Hong Kong?
Most standard health insurance policies in Hong Kong do not cover wellness or longevity medicine — IV therapy, peptides, and GLP-1 for weight management are typically out of pocket. Patients with specific medical diagnoses may have different coverage. It is worth checking your policy directly.
Book a Longevity Consultation at REVIV Hong Kong
Whether you're focused on energy and cognitive performance, metabolic health, physical recovery, or a comprehensive longevity programme, the starting point is a consultation with REVIV's clinical team to understand where you are and what's most relevant for your goals.
Location: 1st Floor, The Plaza, 21 D'Aguilar Street, Central, Hong Kong
Opening hours: Monday to Sunday, 10:00 AM – 7:00 PM
WhatsApp: +852 9867 9183
Sources
Verdin E. NAD+ in Aging, Metabolism, and Neurodegeneration.Science, 2015.
Rajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metabolism, 2018.
Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine, 2023.
Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sexual Medicine Reviews, 2018.
Covarrubias AJ et al. NAD+ Metabolism and its Roles in Cellular Processes During Ageing.Nature Reviews Molecular Cell Biology, 2021.
The material on this page is provided for informational purposes only and is not medical advice. Always consult your doctor before beginning any therapy programme. All therapies are subject to medical screening and doctor consultation to approve responsible treatment.
